| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918826 | Radiotherapy and Oncology | 2012 | 5 Pages |
Abstract
A survey of second cancer after radiotherapy requires follow-up over decades. Preliminary dose response modelling albeit with low case numbers suggests an increased risk from multiportal techniques. To improve risk assessment, prospective out-of-field dosimetry and long-term multicentre data collection are recommended.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Detlef Bartkowiak, Nicole Humble, Peter Suhr, Juliane Hagg, Katharina Mair, Bernd Polivka, Uwe Schneider, Dirk Bottke, Thomas Wiegel,